Results
Trial
Research Area
Duration
Locations
-
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious…
Active, Not Recruiting
Tuberculosis
Results
Trial
Research Area
Duration
Locations
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious…
Active, Not Recruiting
Tuberculosis
A5362 is a study for people with pulmonary tuberculosis (TB) without evidence of resistance to the TB drugs isoniazid (INH)…
Closed to accrual
Tuberculosis
A5341s: Intensive Reservoir Sampling, A5321 Substudy
A5341s: A5321 Sampling Substudy Longitudinal Sampling Substudy of A5321 is collecting information from measures of different HIV reservoirs, including…
Open and enrolling
HIV Cure
This study is for participants who have pulmonary tuberculosis (TB), a bacterial infection in their lungs. Isoniazid (INH) is a…
Closed to accrual
Tuberculosis
About 23 days
The purpose of this study is to see if cenicriviroc mesylate (or CVC) can reduce inflammation of the arteries (the…
Open and enrolling
HIV (and comorbidities)
24 weeks
A5394: Safety, Tolerability, and Impact of Oral TLR8 Agonist Selgantolimod on HBsAg
Open and enrolling
Hepatitis
The first study of a broadly neutralizing antibody called SAR441236 in humans, will determine if an infusion is safe and…
Closed to accrual
HIV (and comorbidities)
Most participants will be followed on study for 24 weeks after their infusion. Participants who receive multiple infusions will be followed for a total of 72 weeks.
A5359: Long-Acting Antiretroviral Therapy in Non-adherent Persons Living with HIV (PLWH)
This four-step study compares Long-Acting (LA) Injectable Antiretroviral Therapy (ART) to standard of care (SOC) oral ART in previously non-adherent…
Open and enrolling
HIV (and comorbidities)
Steps 1-3 combined are a total of 128 weeks. Step 4 lasts 52 weeks.
Will evaluate whether starting antiretroviral drugs very early in HIV infection will limit the virus from getting into hidden areas…
Closed to accrual
HIV Cure
The duration of the study is up to 72 weeks (a year and a half).
Studies differences and changes over time in HIV reservoirs (groups of HIV infected cells that ’hide’ from anti-HIV medications).
Open and enrolling
HIV Cure
Participants will be expected to stay in the study for about 7 years.